Skip to content

Development and Implementation of Mobile Antibiograms to Optimize Empirical Antibiotic Prescriptions Among Prescribers in Tertiary Hospitals in Tanzania

Enhancing the Optimization of Empirical Antibiotic Therapy: Development and Implementation of Mobile Antibiograms in Tertiary Hospitals in Tanzania

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07393308
Acronym
AMR; AMU; DDD
Enrollment
300
Registered
2026-02-06
Start date
2026-02-01
Completion date
2028-06-30
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antimicrobial Prescribing Practices, Antimicrobial Resistance (AMR)

Brief summary

Antimicrobial resistance (AMR) is a critical issue, especially in Africa, with resistance to common antibiotics reaching 100% in some areas. In Tanzania, limited access to culture tests and antibiograms forces healthcare providers to rely on experience for prescribing, heightening AMR risks. This study aims to determine the effectiveness of mobile antibiograms in optimizing empirical antibiotic therapy in tertiary hospitals in Tanzania.

Detailed description

A pragmatic quasi-experimental design (hybrid type 1 trial) will be used to evaluate the effectiveness of mobile antibiograms on antibiotic use. The key role of the antibiogram is to guide empirical treatment of symptomatic infections using antibiotics ie., the antibiogram contains a list of susceptible and resistant antibiotics enabling the prescriber to rationally choose the antibiotic which is effective in clearing the infection. The study employs a three-phase, stepwise approach to assess and enhance antimicrobial use in Tanzanian hospitals. The first phase will be a baseline assessment using World Health Organization's Point Prevalence Survey and defined daily dose (DDD) to determine the pattern of antibiotic utilization and consumption respectively. The second phase involves developing a mobile antibiogram application through a participatory design with healthcare stakeholders. The final phase will use a quasi-experimental design to test the effectiveness of the mobile antibiogram on antimicrobial stewardship metrics like DDD per 1000 patient days, antibiotic appropriateness, infection-related mortality and length of hospital stay. The study sites will be Mbeya Zonal Referral Hospital (MZRH) as the intervention group and Benjamini Mkapa Hospital (BMH) as the control group. Additionally, a mixed-methods design (explanatory sequential design) will be used to assess the acceptability, feasibility, and adoption of the mobile antibiograms.

Interventions

OTHERMobile antibiogram application

A mobile antibiogram application software containing antibiotic sensitivity test results specific to the health facility. This mobile antibiogram application will guide decision support for empirical prescription.

OTHERstandard of care

Participants will be assigned to manual antibiogram only.

Sponsors

Muhimbili University of Health and Allied Sciences
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. All prescribers working in the selected tertiary referral hospitals 2. All prescribers owning smartphones 3. Prescribers who consent to take part in the study

Exclusion criteria

1\. Temporarily employed prescribers

Design outcomes

Primary

MeasureTime frameDescription
Pattern of antibiotic use12 monthsProportional change in antibiotic use among admitted patients

Secondary

MeasureTime frameDescription
Pattern of antibiotic resistance12 monthsNumber of resistances to antibiotics among admitted patients
Acceptability of mobile antibiograms12 months% of acceptability of mobile antibiograms among prescribers
Feasibility of mobile antibiograms12 months% of feasibility mobile antibiogram among prescribers in tertiary referral hospitals in Tanzania
Adoption of mobile antibiogram12 months% of adoption of mobile antibiogram among prescribers in tertiary referral hospitals in Tanzania

Countries

Tanzania

Contacts

CONTACTAlphonce Ignace Marealle, PhD
marealle2010@gmail.com+255713629365
CONTACTWigilya Padili Mikomangwa, MSc
wpad.miko@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026